Exploring anti-cancer activities of epidermal growth factor-immobilized polymeric nanoparticles

Cytotoxic agents targeting the epidermal growth factor receptor (EGFR) exhibit significant potential for cancer therapy as EGFR is overexpressed in various cancers. As alternatives to conventional EGFR inhibitors (EGFRi), which exert side effects on non-cancer cells, EGF-immobilized gold nanoparticl...

Full description

Saved in:
Bibliographic Details
Main Authors: Shota Yamamoto, Chia-Jung Chang, Masao Kamimura, Jun Nakanishi
Format: Article
Language:English
Published: Taylor & Francis Group 2025-02-01
Series:Science and Technology of Advanced Materials
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/14686996.2025.2463316
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832086901308260352
author Shota Yamamoto
Chia-Jung Chang
Masao Kamimura
Jun Nakanishi
author_facet Shota Yamamoto
Chia-Jung Chang
Masao Kamimura
Jun Nakanishi
author_sort Shota Yamamoto
collection DOAJ
description Cytotoxic agents targeting the epidermal growth factor receptor (EGFR) exhibit significant potential for cancer therapy as EGFR is overexpressed in various cancers. As alternatives to conventional EGFR inhibitors (EGFRi), which exert side effects on non-cancer cells, EGF-immobilized gold nanoparticles exhibit selective cytotoxicity in EGFR-overexpressing cancer cells by locally enhancing EGFR activation and modulating signal transduction through a signal condensation mechanism. However, considering real therapeutic applications, it is important to confirm that the same principle can be applied to polymeric nanoparticles, which are more suitable carriers owing to their biodegradability and biocompatibility, remains unclear. Therefore, in this study, we aimed to investigate the anti-cancer activities of EGF-conjugates with two kinds of polymeric nanoparticles: polystyrene nanoparticles and polymeric micelles. Initial mechanistic studies on phosphorylation signaling and cholesterol depletion revealed that EGF-polystyrene nanoparticles exhibited cytotoxicity against human cervical adenocarcinoma HeLa cells via local enhancement of EGFR activity in membrane rafts. Moreover, EGF-polymeric micelles exerted selective anti-cancer effects against EGFRi-resistant MDA-MB468 refractory triple-negative breast cancer cells after optimization of particle size. These results suggest that the unique anti-cancer effects of EGF nanoparticles are not dependent on the carrier platform. Furthermore, EGF nanoparticles exhibited high cytotoxicity against cancer cells responding poorly to conventional EGFR-targeted anti-cancer drugs, showing potential for future medical applications.
format Article
id doaj-art-1fb468ad6e224a168d1001594b6b891c
institution Kabale University
issn 1468-6996
1878-5514
language English
publishDate 2025-02-01
publisher Taylor & Francis Group
record_format Article
series Science and Technology of Advanced Materials
spelling doaj-art-1fb468ad6e224a168d1001594b6b891c2025-02-06T08:49:26ZengTaylor & Francis GroupScience and Technology of Advanced Materials1468-69961878-55142025-02-0110.1080/14686996.2025.2463316Exploring anti-cancer activities of epidermal growth factor-immobilized polymeric nanoparticlesShota Yamamoto0Chia-Jung Chang1Masao Kamimura2Jun Nakanishi3Research Center for Macromolecules & Biomaterials, National Institute for Materials Science (NIMS), Tsukuba, Ibaraki, JapanResearch Center for Macromolecules & Biomaterials, National Institute for Materials Science (NIMS), Tsukuba, Ibaraki, JapanGraduate School of Advanced Engineering, Tokyo University of Science, Katsushika-ku, Tokyo, JapanResearch Center for Macromolecules & Biomaterials, National Institute for Materials Science (NIMS), Tsukuba, Ibaraki, JapanCytotoxic agents targeting the epidermal growth factor receptor (EGFR) exhibit significant potential for cancer therapy as EGFR is overexpressed in various cancers. As alternatives to conventional EGFR inhibitors (EGFRi), which exert side effects on non-cancer cells, EGF-immobilized gold nanoparticles exhibit selective cytotoxicity in EGFR-overexpressing cancer cells by locally enhancing EGFR activation and modulating signal transduction through a signal condensation mechanism. However, considering real therapeutic applications, it is important to confirm that the same principle can be applied to polymeric nanoparticles, which are more suitable carriers owing to their biodegradability and biocompatibility, remains unclear. Therefore, in this study, we aimed to investigate the anti-cancer activities of EGF-conjugates with two kinds of polymeric nanoparticles: polystyrene nanoparticles and polymeric micelles. Initial mechanistic studies on phosphorylation signaling and cholesterol depletion revealed that EGF-polystyrene nanoparticles exhibited cytotoxicity against human cervical adenocarcinoma HeLa cells via local enhancement of EGFR activity in membrane rafts. Moreover, EGF-polymeric micelles exerted selective anti-cancer effects against EGFRi-resistant MDA-MB468 refractory triple-negative breast cancer cells after optimization of particle size. These results suggest that the unique anti-cancer effects of EGF nanoparticles are not dependent on the carrier platform. Furthermore, EGF nanoparticles exhibited high cytotoxicity against cancer cells responding poorly to conventional EGFR-targeted anti-cancer drugs, showing potential for future medical applications.https://www.tandfonline.com/doi/10.1080/14686996.2025.2463316Anti-cancer drugsEgf-nanoparticle conjugatespolymeric micellestriple-negative breast cancer
spellingShingle Shota Yamamoto
Chia-Jung Chang
Masao Kamimura
Jun Nakanishi
Exploring anti-cancer activities of epidermal growth factor-immobilized polymeric nanoparticles
Science and Technology of Advanced Materials
Anti-cancer drugs
Egf-nanoparticle conjugates
polymeric micelles
triple-negative breast cancer
title Exploring anti-cancer activities of epidermal growth factor-immobilized polymeric nanoparticles
title_full Exploring anti-cancer activities of epidermal growth factor-immobilized polymeric nanoparticles
title_fullStr Exploring anti-cancer activities of epidermal growth factor-immobilized polymeric nanoparticles
title_full_unstemmed Exploring anti-cancer activities of epidermal growth factor-immobilized polymeric nanoparticles
title_short Exploring anti-cancer activities of epidermal growth factor-immobilized polymeric nanoparticles
title_sort exploring anti cancer activities of epidermal growth factor immobilized polymeric nanoparticles
topic Anti-cancer drugs
Egf-nanoparticle conjugates
polymeric micelles
triple-negative breast cancer
url https://www.tandfonline.com/doi/10.1080/14686996.2025.2463316
work_keys_str_mv AT shotayamamoto exploringanticanceractivitiesofepidermalgrowthfactorimmobilizedpolymericnanoparticles
AT chiajungchang exploringanticanceractivitiesofepidermalgrowthfactorimmobilizedpolymericnanoparticles
AT masaokamimura exploringanticanceractivitiesofepidermalgrowthfactorimmobilizedpolymericnanoparticles
AT junnakanishi exploringanticanceractivitiesofepidermalgrowthfactorimmobilizedpolymericnanoparticles